The emergency use authorisation for the Oxford-AstraZeneca vaccine is expected within days, Serum Institute CEO Adar Poonawalla said.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.